SCHEMBL6023032

SCHEMBL6023032

[S]c1[c]ccc2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.43
▸ CYP2A6 P11509 6/20 0.43
▸ HSD17B10 Q99714 5/20 0.43
▸ TSHR P16473 3/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ HPRT1 P00492 1/20 0.40
▸ HIF1A Q16665 1/20 0.37
▸ CYP1B1 Q16678 1/20 0.37
▸ CYP1A2 P05177 6/20 0.36
▸ HPGD P15428 3/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ KEAP1 Q14145 1/20 0.36
▸ PTPN22 Q9Y2R2 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ NR3C1 P04150 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL114219 0.75 ALDH1A1 (0.48) ALDH1A1CYP2A6HSD17B10TSHRTDP1
SCHEMBL17911639 0.71 ALDH1A1 (0.43) ALDH1A1CYP2A6HSD17B10TSHRTDP1
SCHEMBL232744 0.71 ALDH1A1 (0.43) ALDH1A1CYP2A6HSD17B10TSHRTDP1
SCHEMBL5518922 0.71 ALDH1A1 (0.50) ALDH1A1CYP2A6HSD17B10TSHRTDP1
SCHEMBL533954 0.71 CYP1A2 (0.46) ALDH1A1CYP2A6HSD17B10TSHRTDP1
SCHEMBL232112 0.71 CYP2A6 (0.46) ALDH1A1CYP2A6HSD17B10TSHRTDP1
SCHEMBL232693 0.71 CYP2A6 (0.43) ALDH1A1CYP2A6HSD17B10TSHRTDP1
SCHEMBL232794 0.71 ALDH1A1 (0.43) ALDH1A1CYP2A6HSD17B10TSHRTDP1
SCHEMBL20507044 0.71 ALDH1A1 (0.43) ALDH1A1CYP2A6HSD17B10TSHRTDP1
SCHEMBL219753 0.71 CYP2A6 (0.46) ALDH1A1CYP2A6HSD17B10TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7144993-B2 Process for the preparation of 4-methyl-7-aminoquinolones CIBA SPECIALTY CHEMICALS CORP. (US) 2006-12-05 — — US disclosed
US-20050222397-A1 Process for the preparation of 4-methyl-7-aminoquinolones CIBA SPECIALTY CHEMICALS CORP. 2005-10-06 — — US disclosed
EP-1453809-A1 PROCESS FOR THE PREPARATION OF 4-METHYL-7-AMINOQUINOLONES Ciba SC Holding AG (CH) 2004-09-08 — — EP disclosed
WO-2003050089-A1 PROCESS FOR THE PREPARATION OF 4-METHYL-7-AMINOQUINOLONES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-06-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222397-A1 Process for the preparation of 4-methyl-7-aminoquinolones CBR1, CBR3, MRPL21 ALDH1A1 2050/4885CYP2A6 87/4885HSD17B10 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback